An Immune-Stimulatory Helix-Loop-Helix Peptide: Selective Inhibition of CTLA-4-B7 Interaction.


Journal

ACS chemical biology
ISSN: 1554-8937
Titre abrégé: ACS Chem Biol
Pays: United States
ID NLM: 101282906

Informations de publication

Date de publication:
21 02 2020
Historique:
pubmed: 17 12 2019
medline: 10 2 2021
entrez: 17 12 2019
Statut: ppublish

Résumé

Molecular-targeting peptides and mini-proteins are promising alternatives to antibodies in a wide range of applications in bioscience and medicine. We have developed a helix-loop-helix (HLH) peptide as an alternative to antibodies to inhibit specific protein interactions. Cytotoxic T lymphocyte antigen-4 (CTLA-4) downregulates immune responses of cytotoxic T-cells by interaction with B7-1, a co-stimulatory molecule expressed on antigen presenting cells (APCs). To induce immune stimulatory activity, we used directed evolution methods to generate a HLH peptide that binds to CTLA-4, inhibiting the CTLA-4-B7-1 interaction and inducing immune stimulatory activity. Yeast-displayed libraries of HLH peptides were constructed and screened against CTLA-4 and identified the binding peptide Y-2, which exhibits a moderate affinity. The affinity of Y-2 was improved by

Identifiants

pubmed: 31841301
doi: 10.1021/acschembio.9b00743
doi:

Substances chimiques

B7-1 Antigen 0
CTLA-4 Antigen 0
CTLA4 protein, human 0
Immunoglobulin Fc Fragments 0
Immunologic Factors 0
Peptide Library 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-368

Auteurs

Tharanga M R Ramanayake Mudiyanselage (TMR)

Department of Veterinary Science, Graduate School of Life and Environmental Sciences , Osaka Prefecture University , 1-58 Rinku-oraikita , Izumisano , Osaka 598-8531 , Japan.

Masataka Michigami (M)

Department of Biological Science, Graduate School of Science , Osaka Prefecture University , 1-1 Gakuen-cho, Naka-ku , Sakai , Osaka 599-8531 , Japan.

Zhengmao Ye (Z)

Department of Biological Science, Graduate School of Science , Osaka Prefecture University , 1-1 Gakuen-cho, Naka-ku , Sakai , Osaka 599-8531 , Japan.

Atsuko Uyeda (A)

Department of Biotechnology, Graduate School of Engineering , Osaka University , 2-1 Yamadaoka , Suita , Osaka 565-0871 , Japan.

Norimitsu Inoue (N)

Department of Tumor Immunology , Osaka International Cancer Institute , 3-1-69 Otemae, Chuo-ku , Osaka-shi , Osaka 541-8567 , Japan.

Kikuya Sugiura (K)

Department of Veterinary Science, Graduate School of Life and Environmental Sciences , Osaka Prefecture University , 1-58 Rinku-oraikita , Izumisano , Osaka 598-8531 , Japan.

Ikuo Fujii (I)

Department of Biological Science, Graduate School of Science , Osaka Prefecture University , 1-1 Gakuen-cho, Naka-ku , Sakai , Osaka 599-8531 , Japan.

Daisuke Fujiwara (D)

Department of Biological Science, Graduate School of Science , Osaka Prefecture University , 1-1 Gakuen-cho, Naka-ku , Sakai , Osaka 599-8531 , Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH